Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: A literature review

European Eating Disorders Review

Volumn 22, Issue 5, 2014, Pages 307-320

  Tortorella, Alfonso ^a   Brambilla, Francesca ^b   Fabrazzo, Michele ^a   Volpe, Umberto ^a   Monteleone, Alessio Maria ^a   Mastromo, Daniele ^a   Monteleone, Palmiero ^a,c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

anorexia nervosa; bulimia nervosa; central peptides; eating disorders; feeding regulators; neuroendocrinology; peripheral peptides

Indexed keywords

ADIPONECTIN; AGOUTI RELATED PEPTIDE; ALPHA INTERMEDIN; APELIN; CENTRAL PEPTIDE; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; GALANIN; GASTRIN; GASTRIN RELEASING PEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE; INSULIN; LEPTIN; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTENSIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESTATIN; OPIATE PEPTIDE; OXYTOCIN; PANCREAS POLYPEPTIDE; PEPTIDE; PEPTIDE YY; PERIPHERAL PEPTIDE; PROTIRELIN; RESISTIN; SOMATOSTATIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

ANOREXIA NERVOSA; BODY WEIGHT; BULIMIA; ENERGY HOMEOSTASIS; ENERGY METABOLISM; FEEDING BEHAVIOR; HOMEOSTASIS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REGULATORY MECHANISM; REVIEW;

ANOREXIA NERVOSA; BULIMIA NERVOSA; CENTRAL PEPTIDES; EATING DISORDERS; FEEDING REGULATORS; NEUROENDOCRINOLOGY; PERIPHERAL PEPTIDES;

ANOREXIA NERVOSA; APPETITE; BODY WEIGHT; BULIMIA NERVOSA; FEEDING BEHAVIOR; HOMEOSTASIS; HUMANS; PEPTIDES;

EID: 84905979391     PISSN: 10724133     EISSN: 10990968     Source Type: Journal    
DOI: 10.1002/erv.2303     Document Type: Review

References (147)

1. Adrian, T. E., Ferri, G. L., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., &, Bloom, S. R., (1985). Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology, 89, 1070-1077.
2. Bailer, U. F., &, Kaye, W. H., (2003). A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa. Current Drug Targets: CNS & Neurological Disorders, 2, 53-59.
3. Balligand, J. L., Brichard, S. M., Brichard, V., Desager, J. P., &, Lambert, M., (1998). Hypoleptinemia in patients with anorexia nervosa: Loss of circadian rhythm and unresponsiveness to short-term refeeding. European Journal of Endocrinology, 138, 415-420.
4. Baranowska, B., (1990). Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa? Psychoneuroendocrinology, 15, 371-379.
5. Baranowska, B., Radzikowska, M., Wasilewska-Dziubinska, E., Roguski, K., &, Boroviec, M., (2000). Disturbed release of gastrointestinal peptides in anorexia nervosa. Diabetes, Obesity and Metabolism, 2, 99-103.
6. Baranowska, B., Wolinska-Witort, E., Wasilewska-Dziubinska, E., Roguski, K., &, Chmielowska, M., (2001). Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa. Neuroendocrinology Letters, 22, 356-358.
7. Berrettini, W. H., Kaye, W. H., Sunderland, T., May, C., Gwirtsman, H. E., Mellow, A., et al. (1988). Galanin immunoreactivity in human CSF: Studies in eating disorders and Alzheimer's disease. Neuropsychobiology, 19, 64-68.
8. Biebermann, H., Kühnen, P., Kleinau, G., &, Krude, H., (2012). The neuroendocrine circuitry controlled by POMC, MSH, and AGRP. Handbook of Experimental Pharmacology, 209, 47-75. doi: 10.1007/978-3-642-24716-3-3.
9. Blundell, J. E., Goodson, S., &, Halford, J. C. G., (2001). Regulation of appetite: Role of leptin in signaling systems for drive and satiety. International Journal of Obesity and Related Metabolic Disorders, 25, 529-534.
10. Brambilla, F., Brunetta, M., Draisci, A., Peirone, A., Perna, G., Sacerdote, P., et al. (1995). T-lymphocyte concentrations of cholecystokinin-8 and beta-endorphin in eating disorders: II. Bulimia nervosa. Psychiatry Research, 59, 51-56.
11. Brambilla, F., Brunetta, M., Peirone, A., Perna, G., Sacerdote, P., Manfredi, B., et al. (1995). T-lymphocyte cholecystokinin-8 and beta-endorphin concentrations in eating disorders: I. Anorexia nervosa. Psychiatry Research, 59, 43-50.
12. Brambilla, F., &, Monteleone, P., (2003). Physical complications and physiological aberrations in eating disorders: A review. In, M. Maj, K. Halmi, J. J. Lopez-Ibor, &, N. Sartorius, (Eds.), Eating disorders. Chichester, England: Wiley et al. Sons Ltd, pp. 139-192.
13. Brambilla, F., Ferrari, E., Petraglia, F., Facchinetti, F., Catalano, M., &, Genazzani, A. R., (1991). Peripheral opioid secretory pattern in anorexia nervosa. Psychiatry Research, 39, 115-127.
14. Brambilla, F., Monteleone, P., Bortolotti, F., Dalle Grave, R., Todisco, P., Favaro, A., et al. (2003). Persistent amenorrhoea in weight-recovered anorexics: Psychological and biological aspects. Psychiatry Research, 118, 249-257.
15. Brambilla, F., Monteleone, P., &, Maj, M., (2009). Glucagon-like peptide-1 secretion in bulimia nervosa. Psychiatry Research, 169, 82-85. doi: 10.1016/j.psychres.2008.06.040.
16. Brandys, M. K., Kas, M. J., van Elburg, A. A., Campbell, I. C., &, Adan, R. A., (2011). A meta-analysis of circulating BDNF concentrations in anorexia nervosa. World Journal of Biological Psychiatry, 12, 444-454.
17. Brandys, M. K., Kas, M. J., van Elburg A. A., Ophoff, R., Slof-Op't Landt, M. C., &, Middeldorp, C. M., (2011). The Val66Met polymorphism of the BDNF gene in anorexia nervosa: New data and a meta-analysis. World Journal of Biological Psychiatry, 14, 441-451. doi: 10.3109/15622975.2011.605470.
18. Brewerton, T. D., Lydiard, R. B., Laraia, M. T., Shook, J. E., &, Ballenger, J. C., (1992). CSF beta-endorphin and dynorphin in bulimia nervosa. The American Journal of Psychiatry, 149, 1086-1090.
19. Chiodera, P., Volpi, R., Capretti, L., Marchesi, C., d'Amato, L., De Ferri, A., et al. (1991). Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa. Metabolism, 40, 1226-1230.
20. Chiodera, P., Volpi, R., Marchesi, C., Caffarra, P., De Ferri, A., Capretti, L., et al. (1993). Reduction in the arginine vasopressin responses to metoclopramide and insulin-induced hypoglycemia in normal weight bulimic women. Neuroendocrinology, 57, 907-911.
21. Cuntz, U., Enck, P., Frühauf, E., Lehnert, P., Riepl, R. L., &, Fichter, M. M., (2013). Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa. PLoS One, 8, e54457. doi: 10.1371/journal.pone.0054457.
22. Degen, L., Matzinger, D., Drewe, J., &, Beglinger, C., (2001). The effect of cholecystokinin in controlling appetite and food intake in humans. Peptides, 22, 1265-1269.
23. Demitrack, M. A., Kalogeras, K. T., Altemus, M., Pigott, T. A., Listwak, S. J., &, Gold, P. W., (1992). Plasma and cerebrospinal fluid measures of arginine vasopressin secretion in patients with bulimia nervosa and in healthy subjects. Journal of Clinical Endocrinology and Metabolism, 74, 1277-1283.
24. Demitrack, M. A., Lesem, M. D., Listwak, S. J., Brandt, H. A., Jimerson, D. C., &, Gold, P. W., (1990). CSF oxytocin in anorexia nervosa and bulimia nervosa: Clinical and pathophysiologic considerations. The American Journal of Psychiatry, 147, 882-886.
25. Devlin, M. J., Walsh, B. T., Kral, J. G., Heymsfield, S. B., Pi-Sunyer, F. X., &, Dantzic, S., (1990). Metabolic abnormalities in bulimia nervosa. Archives of General Psychiatry, 47, 144-148.
26. Djurovic, M., Pekic, S., Petakov, M., Damjanovic, S., Doknic, M., Dieguez, C., et al. (2004). Gonadotropin response to clomiphene and plasma leptin levels in weight recovered but amenorrhoeic patients with anorexia nervosa. Journal of Endocrinological Investigation, 27, 523-527.
27. Dolezalova, R., Lacinova, Z., Dolinkova, M., Kleiblova, P., Haluzikova, D., Housa, D., et al. (2007). Changes of endocrine function of adipose tissue in anorexia nervosa: Comparison of circulating levels versus subcutaneous mRNA expression. Clinical Endocrinology, 67, 674-678.
28. Dostálová, I., Kunesova, M., Duskova, J., Papezová, H., &, Nedvídková, J., (2006). Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition, 22, 977-983.
29. Dostálová, I., Sedlácková, D., Papezová, H., Nedvídková, J., &, Haluzík, M., (2009). Serum visfatin levels in patients with anorexia nervosa and bulimia nervosa. Physiological Research, 58, 903-907.
30. Dostálová, I., Smitka, K., Papezová, H., Kvasnicková, H., &, Nedvídková, J., (2007). Increased insulin sensitivity in patients with anorexia nervosa: The role of adipocytokines. Physiological Research, 56, 587-594.
31. Ehrlich, S., Salbach-Andrae, H., Eckart, S., Merle, J.V., Burghardt, R., Pfeiffer, E., et al. (2009). Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa. Journal of Psychiatry & Neuroscience, 34, 323-329.
32. Fetissov, S. O., Hallman, J., Oreland, L., Af Klinteberg, B., Grenbäck, E., Hulting, A. L., et al. (2002). Autoantibodies against αMSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proceedings of the National Academy of Sciences of the United States of America, 99, 17155-17160.
33. Fetissov, S. O., Harro, J., Jaanisk, M., Järv, A., Podar, I., Allik, J., et al. (2005). Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proceedings of the National Academy of Sciences of the United States of America, 102, 14865-14870.
34. Frank, G. K., Kaye, W. H., Ladenheim, E. E., &, McConaha, C., (2001). Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa. Appetite, 37, 9-14.
35. Frank, G. K., Kaye, W. H., Sahu, A., Fernstrom, J., &, McConaha, C., (2001). Could reduced cerebrospinal fluid (CSF) galanin contribute to restricted eating in anorexia nervosa? Neuropsychopharmacology, 24, 706-709.
36. Frank, G. K., Kaye, W. H., Altemus, M., &, Greeno, C. G., (2000). CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype. Biological Psychiatry, 48, 315-318.
37. Fujimoto, S., Inui, A., Kiyota, N., Seki, W., Koide, K., Takamiya, S., et al. (1997). Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa. Biological Psychiatry, 41, 1068-1070.
38. Fullerton, D. T., Swift, W. J., Getto, C. J., &, Carlson, I. H., (1986). Plasma immunoreactive beta-endorphin in bulimics. Psychological Medicine, 16, 59-63.
39. Garg, A., (2007). The ongoing saga of obestatin: Is it a hormone? Journal of Clinical Endocrinology and Metabolism, 92, 3396-3398.
40. Gendall, K. A., Kaye, W. H., Altemus, M., McConaha, C. W., &, La Via, M. C., (1999). Leptin, neuropeptide Y, and peptide YY in long term recovered eating disorder patients. Biological Psychiatry, 46, 292-299.
41. Geracioti, T. D., Liddle, R. A., Altemus, M., Demitrack, M. A., &, Gold, P. W., (1992). Regulation of appetite and cholecystokinin secretion in anorexia nervosa. The American Journal of Psychiatry, 149, 958-961.
42. Germain, N., Galusca, B., Grouselle, D., Frere, D., Billard, S., &, Epelbaum, J., (2010). Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 95, 3057-3062. doi: 10.1210/jc.2009-2196.
43. Germain, N., Galusca, B., Le Roux, C. W., Bossu, C., Ghatei, M. A., Lang, F., et al. (2007). Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. American Journal of Clinical Nutrition, 85, 967-971.
44. Gerner, R. H., &, Yamada, T., (1982). Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Research, 22, 298-302.
45. Gerner, R. H., Sharp, B., &, Catlin, D. H., (1982). Peripherally administered beta-endorphin increases cerebrospinal fluid endorphin immunoreactivity. Journal of Clinical Endocrinology and Metabolism, 55, 358-360.
46. Gianotti, L., Rolla, M., Arvat, E., Belliti, D., Valetto, M. R., Ferdeghini, M., et al. (1999). Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. Biological Psychiatry, 45, 334-339.
47. Gold, P. W., Kaye, W., Robertson, G. L., &, Ebert, M., (1983). Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. New England Journal of Medicine, 308, 1117-1123.
48. Gosnell, B. A., &, Levine, A. S., (2009). Reward systems and food intake: Role of opioids. International Journal of Obesity, 33, S54-S58. doi: 10.1038/ijo.2009.73.
49. Gourcerol, G., &, Taché, Y., (2007). Obestatin-a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterology and Motility, 19, 161-165.
50. Gwirtsman, H. E., Roy-Byrne, P., Yager, J., &, Gerner, R. H., (1983). Neuroendocrine abnormalities in bulimia. The American Journal of Psychiatry, 140, 559-563.
51. Haas, V., Onur, S., Paul, T., Nutzinger, D. O., Bosy-Westphal, A., &, Hauer, M., (2005). Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. American Journal of Clinical Nutrition, 81, 889-896.
52. Hannon-Engel, S. L., Filin, E. E., &, Wolfe, B. E., (2013). CCK response in bulimia nervosa and following remission. Physiology and Behavior, 122, 56-61. doi: 10.1016/j.physbeh.2013.08.014.
53. Harada, T., Nakahara, T., Yasuhara, D., Kojima, S., Sagiyama, K., Amitani, H., et al. (2008). Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biological Psychiatry, 15, 245-247.
54. Harty, R. F., Pearson, P. H., Solomon, T. E., &, McGuigan, J. E., (1991). Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa. Regulatory Peptides, 36, 141-150.
55. Hebebrand, J., Muller, T. D., Holtkamp, K., &, Herpertz-Dahlmann, B., (2007). The role of leptin in anorexia nervosa: Clinical implications. Molecular Psychiatry, 12, 23-35.
56. Hillebrand, J. J., Koeners, M. P., de Rijke, C. E., Kas, M. J., &, Adan, R. A., (2005). Leptin treatment in activity-based anorexia. Biological Psychiatry, 58, 165-171.
57. Hökfelt, T., Stanic, D., Sanford, S. D., Gatlin, J. C., Nilsson, I., Paratcha, G., et al. (2008). NPY and its involvement in axon guidance, neurogenesis, and feeding. Nutrition, 24, 860-868. doi: 10.1016/j.nut.2008.06. 010.
58. Holtkamp, K., Hebebrand, J., Mika, C., Heer, M., Heussen, N., &, Herpertz-Dahlmann, B., (2004). High serum leptin levels subsequent to weight gain predict renewed weight loss in patients with anorexia nervosa. Psychoneuroendocrinology, 29, 791-797.
59. Holtkamp, K., Herpertz-Dahlmann, B., Mika, C., Heer, M., Heussen, N., Fichter, M., et al. (2003). Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 88, 5169-5174.
60. Hotta, M., Ohwada, R., Katakami, H., Shibasaki, T., Hizuka, N., &, Takano, K., (2004). Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 89, 5707-5712.
61. Hotta, M., Shibasaki, T., Masuda, A., Imaki, T., Demura, H., &, Ling, N., (1986). The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients. Journal of Clinical Endocrinology and Metabolism, 62, 319-324.
62. Housova, J., Anderlova, K., Krizová, J., Haluzikova, D., Kremen, J., Kumstyrová, T., et al. (2005). Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. Journal of Clinical Endocrinology and Metabolism, 90, 1366-1370.
63. Iwahashi, H., Funahashi, T., Kurokawa, N., Sayama, K., Fukuda, E., Okita, K., et al. (2003). Plasma adiponectin levels in women with anorexia nervosa. Hormone and Metabolic Research, 35, 537-540.
64. Jamaluddin, M. S., Weakley, S. M., Yao, Q., &, Chen, C., (2012). Resistin: Functional roles and therapeutic considerations for cardiovascular disease. British Journal of Pharmacology, 165, 622-632. doi: 10.1111/j.1476-5381.2011.01369.x.
65. Kalra, S. P., &, Kalra, P. S., (1996). Nutritional infertility: The role of the interconnected hypothalamic neuropeptide Y-galanin-opioid network. Frontiers in Neuroendocrinology, 17, 371-401.
66. Kaye, W. H., (1996). Neuropeptide abnormalities in anorexia nervosa. Psychiatry Research, 62, 65-74.
67. Kaye, W. H., Berrettini, W. H., Gwirtsman, H. E., Chretien, M., Gold, P. W., George, D. T., et al. (1987). Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa. Life Sciences, 41, 2147-2155.
68. Kaye, W. H., Berrettini, W., Gwirtsman, H., &, George, D. T., (1990). Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Archives of General Psychiatry, 47, 548-556.
69. Kaye, W., Fudge, J. L., &, Paulus, M., (2009). New insights into symptoms and neurocircuit function of anorexia nervosa. Nature Reviews Neuroscience, 10, 573-584. doi: 10.1038/nrn2682.
70. Kaye, W. H., Pickar, D., Naber, D., &, Ebert, M. H., (1982). Cerebrospinal fluid opioid activity in anorexia nervosa. The American Journal of Psychiatry, 139, 643-645.
71. Kaye, W. H., Rubinow, D., Gwirtsman, H. E., George, D. T., Jimerson, D. C., &, Gold, P. W., (1988). CSF somatostatin in anorexia nervosa and bulimia: Relationship to the hypothalamic pituitary-adrenal cortical axis. Psychoneuroendocrinology, 13, 265-272.
72. Kim, E. R., &, Mizuno, T. M., (2010). Role of neurotensin receptor 1 in the regulation of food intake by neuromedins and neuromedin-related peptides. Neuroscience Letters, 468, 64-67.
73. Kinzig, K. P., Coughlin, J. W., Redgrave, G. W., Moran, T. H., &, Guarda, A. S., (2007). Insulin, glucose, and pancreatic polypeptide responses to a test meal in restricting type anorexia nervosa before and after weight restoration. American Journal of Physiology, Endocrinology and Metabolism, 292, 1441-1446.
74. Kissileff, H. R., Wentzlaff, T. H., Guss, J. L., Walsh, B. T., Devlin, M. J., &, Thornton, J. C., (1996). A direct measure of satiety disturbance in patients with bulimia nervosa. Physiology and Behavior, 60, 1077-1085.
75. Kojima, S., Nakahara, T., Nagai, N., Muranaga, T., Tanaka, M., Yasuhara, D., et al. (2005). Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clinical Endocrinology, 62, 74-78.
76. Krahn, D. D., &, Gosnell, B. A., (1989). Corticotropin-releasing hormone: Possible role in eating disorders. Psychiatric Medicine, 7, 235-245.
77. Lawson, E. A., Donoho, D. A., Blum, J. I., Meenaghan, E. M., Misra, M., Herzog, D. B., et al. (2011). Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. Journal of Clinical Psychiatry, 72, 1546-1551. doi: 10.4088/JCP.10m06617.
78. Lawson, E. A., Holsen, L. M., Santin, M., Meenaghan, E., Eddy, K. T., Becker, A. E., et al. (2012). Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 97, 1898-1908. doi: 10.1210/jc.2012-1702.
79. Lesem, M. D., Berrettini, W. H., Kaye, W. H., &, Jimerson, D. C., (1991). Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia. Biological Psychiatry, 29, 244-252.
80. Lesem, M. D., Kaye, W. H., Bissette, G., Jimerson, D. C., &, Nemeroff, C. B., (1994). Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa. Biological Psychiatry, 35, 48-53.
81. Lob, S., Pickel, J., Bidlingmaier, M., Schaaf, L., Backmund, H., &, Gerlinghoff, M., (2003). Serum leptin monitoring in anorectic patients during refeeding therapy. Experimental and Clinical Endocrinology and Diabetes, 111, 278-282.
82. Lofrano-Prado, M. C., Prado, W. L., de Piano, A., Tock, L., Caranti, D. A., Nascimento, C. M., et al. (2011). Eating disorders in adolescents: correlations between symptoms and central control of eating behaviour. Eating Behaviors, 12, 78-82. doi: 10.1016/j.eatbeh.2010.09.008.
83. Lõpez, M., Nogueiras, R., Tena-Sempere, M., &, Diéguez, C., (2010). Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis. Acta Physiologica, 198, 325-334. doi: 10.1111/j.1748-1716.2009.02042.x.
84. Lydiard, R. B., Brewerton, T. D., Fossey, M. D., Laraia, M. T., Stuart, G., &, Beinfeld, M. C., (1993). CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. The American Journal of Psychiatry, 150, 1099-1101.
85. Mercader, J. M., Fernández-Aranda, F., Gratacòs, M., Aguera, Z., Forcano, L., Ribasés, M., et al. (2010). Correlation of BDNF blood levels with interoceptive awareness and maturity fears in anorexia and bulimia nervosa patients. Journal of Neural Transmission, 117, 505-512. doi: 10.1007/s00702-010-0377-8.
86. Mercader, J. M., Ribasès, M., Gratacòs, M., Gonzàlez, J. R., Bayès, M., de Cid, R., et al. (2007). Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes, Brain and Behavior, 6, 706-716.
87. Merle, J. V., Haas, V., Burghardt, R., Döhler, N., Schneider, N., Lehmkuhl, U., et al. (2011). Agouti-related protein in patients with acute and weight-restored anorexia nervosa. Psychological Medicine, 41, 2183-2192. doi: 10.1017/S0033291711000365.
88. Mihaly, E., Fekete, C., Tatro, J. B., Liposits, Z., Stopa, E. G., &, Lechan, R. M., (2000). Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. Journal of Clinical Endocrinology and Metabolism, 85, 2596-2603.
89. Misra, M., &, Klibanski, A., (2009). Neuroendocrine consequences of anorexia nervosa in adolescents. Endocrine Development, 17, 197-214. doi: 10.1159/000262540.
90. Misra, M., Miller, K., Herzog, D., Ramaswamy, K., Aggarwal, A., Almzan, C., et al. (2004). Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. Journal of Clinical Endocrinology and Metabolism, 89, 1605-1612.
91. Misra, M., Miller, K. K., Tsai, P., Gallagher, K., Lin, A., Lee, N., et al. (2006). Elevated peptide YY levels in adolescent girls with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 91, 1027-1033.
92. Mitsukawa, K., Lu, X., &, Bartfai, T., (2008). Galanin, galanin receptors and drug targets. Cellular and Molecular Life Sciences, 65, 1796-1805. doi: 10.1007/s00018-008-8153-8.
93. Monteleone, P., (2011). New frontiers in endocrinology of eating disorders. Current Topics in Behavioral Neurosciences, 6, 189-208. doi: 10.1007/7854-2010-87.
94. Monteleone, P., &, Maj, M., (2013). Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: Beyond the homeostatic control of food intake. Psychoneuroendocrinology, 38, 312-330. doi: 10.1016/j.psyneuen. 2012.10.021.
95. Monteleone, P., Bortolotti, F., Fabrazzo, M., La Rocca, A., Fuschino, A., &, Maj, M., (2000). Plasma leptin response to acute fasting and refeeding in untreated women with bulimia nervosa. Journal of Clinical Endocrinology and Metabolism, 85, 2499-2503.
96. Monteleone, P., Castaldo, E., &, Maj, M., (2008). Neuroendocrine dysregulation of food intake in eating disorders. Regulatory Peptides, 149, 39-50. doi: 10.1016/j.regpep.2007.10.007.
97. Monteleone, P., Di Lieto, A., Tortorella, A., Longobardi, N., &, Maj, M., (2000). Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder: relationship to body weight, eating patterns, psychopathology and endocrine changes. Psychiatry Research, 94, 121-129.
98. Monteleone, P., Fabrazzo, M., Martiadis, V., Fuschino, A., Serritella, C., Milici, N., et al. (2003). Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorder. Journal of Clinical Endocrinology and Metabolism, 88, 5387-5391.
99. Monteleone, P., Fabrazzo, M., Martiadis, V., Serritella, C., Pannuto, M., &, Maj, M., (2005). Circulating brain-derived neurotrophic factor decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder, relationships to co-morbid depression, psychopathology and hormonal variables. Psychological Medicine, 35, 897-905.
100. Monteleone, P., Fabrazzo, M., Tortorella, A., Fuschino, A., &, Maj, M., (2002). Opposite modifications in circulating leptin and soluble leptin receptor across the eating disorder spectrum. Molecular Psychiatry, 7, 641-646.
101. Monteleone, P., Fabrazzo, M., Tortorella, A., Martiadis, V., Serritella, C., &, Maj, M., (2005). Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa. Psychoneuroendocrinology, 30, 243-250.
102. Monteleone, P., Martiadis, V., Colurcio, B., &, Maj, M., (2002). Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa. Psychosomatic Medicine, 64, 874-879.
103. Monteleone, P., Martiadis, V., Fabrazzo, M., Serritella, C., &, Maj, M., (2003). Ghrelin and leptin responses to food ingestion in bulimia nervosa: Implications for binge-eating and compensatory behaviours. Psychological Medicine, 33, 1387-1394.
104. Monteleone, P., Martiadis, V., Rigamonti, A. E., Fabrazzo, M., Giordani, C., Muller, E. E., et al. (2005). Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biological Psychiatry, 57, 926-931.
105. Monteleone, P., Serritella, C., Martiadis, V., Scognamiglio, P., &, Maj M., (2008). Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. Journal of Clinical Endocrinology and Metabolism, 93, 4418-4421. doi: 10.1210/jc.2008-1138.
106. Monteleone, P., Serritella, C., Scognamiglio, P., &, Maj, M., (2009). Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa. Psychoneuroendocrinology, 5, 284-288. doi: 10.1016/j.psyneuen.2009.07.001.
107. Monteleone, P., Tortorella, A., Martiadis, V., Serritella, C., Fuschino, A., &, Maj, M., (2004). Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosomatic Medicine, 66, 744-748.
108. Moriya, J., Takimoto, Y., Yoshiuchi, K., Shimosawa, T., &, Akabayashi A., (2006). Plasma agouti-related protein levels in women with anorexia nervosa. Psychoneuroendocrinology, 31, 1057-1061.
109. Naessén, S., Carlström, K., Holst, J. J., Hellström, P. M., &, Hirschberg, A. L., (2011). Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal. American Journal of Clinical Nutrition, 94, 967-972. doi: 10.3945/ajcn.111.014837.
110. Nakahara, T., Harada, T., Yasuhara, D., Shimada, N., Amitani, H., Sakoguchi, T., et al. (2008). Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biological Psychiatry, 64, 252-255.
111. Nakahara, T., Kojima, S., Tanaka, M., Yasuhara, D., Harada, T., Sagiyama, K., et al. (2007). Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. Journal of Psychiatric Research, 41, 814-820.
112. Nakai, Y., Hosoda, H., Nin, K., Ooya, C., Hayashi, H., Akamizu, T., et al. (2003). Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. European Journal of Endocrinology, 149, R1-R3.
113. Nakazato, M., Hashimoto, K., Shimizu, E., Kumakiri, C., Koizumi, H., Okamura, N., et al. (2003). Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biological Psychiatry, 15, 485-490.
114. Nakazato, M., Hashimoto, K., Yoshimura, K., Hashimoto, T., Shimizu, E., &, Iyo, M., (2006). No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery. Progress in Neuropsychopharmacology and Biological Psychiatry, 30, 1117-1121.
115. Nedvidkova, J., Krykorkova, I., Bartak, V., Papezova, H., Gold, P. W., Alesci, S., et al. (2003). Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 88, 1678-1682.
116. Nedvídková, J., Papezová, H., Haluzík, M., &, Schreiber, V., (2000). Interaction between serum leptin levels and hypothalamo-hypophyseal-thyroid axis in patients with anorexia nervosa. Endocrine Research, 26, 219-230.
117. Nemeroff, C. B., Bissette, G., Widerlov, E., Beckmann, H., Gerner, R., Manberg, P. J., et al. (1989). Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 1, 16-20.
118. Nogueira, J. P., Maraninchi, M., Lorec, A. M., Corroller, A. B., Nicolay, A., Gaudart, J., et al. (2010). Specific adipocytokines profiles in patients with hyperactive and/or binge/purge form of anorexia nervosa. European Journal of Clinical Nutrition, 64, 840-844. doi: 10.1038/ejcn.2010.66.
119. Numan, S., &, Seroogy, K. B., (1999). Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons. A double-label in situ hybridization study. Journal of Comparative Neurology, 403, 295-308.
120. Otto, B., Tschop, M., Fruhauf, E., Heldwein, W., Fichter, M., Otto, C., et al. (2005). Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology, 30, 577-581.
121. Pirke, K. M., Friess, E., Kellner, M. B., Krieg, J. C., &, Fichter, M. M., (1994). Somatostatin in eating disorders. International Journal of Eating Disorders, 15, 99-102.
122. Pirke, K. M., Philipp, E., Friess, E., Kellner, B., Wilkens, T., Krieg, J. C., et al. (1993). The role of gastrointestinal hormone secretion in eating disorders. Advances in Biosciences, 60, 75-79.
123. Prince, A. C., Brooks, S. J., Stahl, D., &, Treasure, J., (2009). Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders. American Journal of Clinical Nutrition, 89, 755-765. doi: 10.3945/ajcn.2008.27056.
124. Qi, Y., Takahashi, N., Hileman, S. M., Patel, H. R., Berg, A. H., Pajvani, U. B., et al. (2004). Adiponectin acts in the brain to decrease body weight. Nature Medicine, 10, 524-529.
125. Sedlackova, D., Kopeckova, J., Papezova, H., Hainer, V., Kvasnickova, H., Hill, M., et al. (2012). Comparison of high-carbohydrate and high-protein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosa. Nutrition & Metabolism, 9, 52. doi: 10.1186/1743-7075-9-52.
126. Sedlackova, D., Kopeckova, J., Papezova, H., Vybìral, S., Kvasnickova, H., Hill, M., et al. (2011). Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast. Physiological Research, 60, 165-173.
127. Stock, S., Leichner, P., Wong, A. C., Ghatei, M. A., Kieffer, T. J., Bloom, S. R., et al. (2005). Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. Journal of Clinical Endocrinology and Metabolism, 90, 2161-2168.
128. Tagami, T., Satoh, N., Usui, T., Yamada, K., Shimatsu, A., &, Kuzuya, H., (2004). Adiponectin in anorexia nervosa and bulimia nervosa. Journal of Clinical Endocrinology and Metabolism, 89, 1833-1837.
129. Taha, S. A., (2010). Preference or fat? Revisiting opioid effects on food intake. Physiology and Behavior, 100, 429-437. doi: 10.1016/j.physbeh.2010.02. 027.
130. Tamai, H., Takemura, J., Kobayashi, N., Matsubayashi, S., Matsukura, S., &, Nakagawa, T., (1993). Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism, 45, 581-584.
131. Tanaka, M., Narau, T., Nagai, N., Kuroki, N., Shiiya, T., Nakazato, M., et al. (2003). Habitual binge/purge behaviour influences circulating ghrelin levels in eating disorders. Journal of Psychiatric Research, 37, 17-22.
132. Tanaka, M., Naruo, T., Yasuhara, D., Tatebe, Y., Nagai, N., Shiiya, T., et al. (2003). Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology, 28, 829-835.
133. Tanaka, M., Tatebe, Y., Nakahara, T., Yasuhara, D., Sagiyama, K., Muranaga, T., et al. (2003). Eating pattern and the effect of oral glucose on ghrelin and insulin secretion in patients with anorexia nervosa. Clinical Endocrinology, 59, 574-579.
134. Terra, X., Auguet, T., Agüera, Z., Quesada, I. M., Orellana-Gavaldà, J. M., &, Aguilar, C., (2013). Adipocytokine levels in women with anorexia nervosa. Relationship with weight restoration and disease duration. International Journal of Eating Disorders, 46, 855-861. doi: 10.1002/eat.22166.
135. Tomasik, P. J., Sztefko, K., &, Malek, A., (2002). GLP-1 as a satiety factor in children with eating disorders. Hormone and Metabolic Research, 34, 77-80.
136. Tomasik, P. J., Sztefko, K., &, Starzyk, J., (2004). Cholecystokinin, glucose dependent insulinotropic peptide and glucagon-like peptide 1 secretion in children with anorexia nervosa and simple obesity. Journal of Pediatric Endocrinology and Metabolism, 17, 1623-1631.
137. Tomasik, P. J., Sztefko, K., Starzyk, J., Rogatko, I., &, Szafran, Z., (2005). Entero-insular axis in children with anorexia nervosa. Psychoneuroendocrinology, 30, 364-372.
138. Troisi, A., Di Lorenzo, G., Lega, I., Tesauro, M., Bertoli, A., Leo, R., et al. (2005). Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology, 81, 259-266.
139. Uehara, M., Yasuhara, D., Nakahara, T., Harada, T., Koyama, K. I., Ushikai, M., et al. (2011). Increase in energy intake leads to a decrease in
140. Waller, D. A., Kiser, R. S., Hardy, B. W., Fuchs, I., Feigenbaum, L. P., &, Uauy, R., (1986). Eating behaviour and plasma beta-endorphin in bulimia. American Journal of Clinical Nutrition, 44, 20-23.
141. Walsh, B. T., (2002). Psychobiology of eating behaviour in bulimia. International Journal of Neuropsychopharmacology, 5, S40-S43.
142. Yamada, H., Yoshimura, C., Nakajima, T., &, Nagata, T., (2012). Recovery of low plasma BDNF over the course of treatment among patients with bulimia nervosa. Psychiatry Research, 198, 448-451. doi: 10.1016/j.psychres. 2011.12.015.
143. Zhang, J. V., Ren, P. G., Avsian-Kretchmer, O., Luo, C. W., Rauch, R., &, Klein, C., (2005). Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science, 310, 996-999.
144. Ziora, K. T., Oświecimska, J. M., Swietochowska, E., Ostrowska, Z., Stojewska, M., &, Gorczyca, P., (2011a). Assessment of serum levels resistin in girls with anorexia nervosa. Part II. Relationships between serum levels of resistin and thyroid, adrenal and gonadal hormones. Neuro Endocrinology Letters, 32, 697-703.
145. Ziora, K. T., Oświecimska, J. M., Swietochowska, E., Ostrowska, Z., Stojewska, M., Gorczyca, P., et al. (2011b). Assessment of serum levels resistin in girls with anorexia nervosa. Part I. Relationship between resistin and body mass index. Neuro Endocrinology Letters, 32, 691-696.
146. Ziora, K., Oświecimska, J., Swietochowska, E., Ziora, D., Ostrowska, Z., &, Stojewska, M., (2010). Assessment of serum apelin levels in girls with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 95, 2935-2941.
147. Ziora, K., Oświȩcimska, J., Swiȩtochowska, E., Ziora, D., Stojewska, M., Suwała, A., et al. (2012). Assessment of serum visfatin levels in girls with anorexia nervosa. Clinical Endocrinology, 76, 514-519. doi: 10.1111/j.1365-2265.2011.04181.x.